BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng G, Hardy M, Topchyan P, Zander R, Volberding P, Cui W, Kalyanaraman B. Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects. iScience 2021;24:102673. [PMID: 34189437 DOI: 10.1016/j.isci.2021.102673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng G, Hardy M, You M, Kalyanaraman B. Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation. Sci Rep 2022;12:5143. [PMID: 35332210 DOI: 10.1038/s41598-022-08984-6] [Reference Citation Analysis]
2 Zhao S, Heng N, Wang H, Wang H, Zhang H, Gong J, Hu Z, Zhu H. Mitofusins: from mitochondria to fertility. Cell Mol Life Sci 2022;79:370. [PMID: 35725948 DOI: 10.1007/s00018-022-04386-z] [Reference Citation Analysis]
3 Kalyanaraman B. Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer. RSC Chem Biol 2021;2:1402-14. [PMID: 34704045 DOI: 10.1039/d1cb00042j] [Reference Citation Analysis]
4 Kalyanaraman B. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research. FASEB J 2022;36:e22226. [PMID: 35233843 DOI: 10.1096/fj.202101862R] [Reference Citation Analysis]
5 Appiah MG, Park EJ, Akama Y, Nakamori Y, Kawamoto E, Gaowa A, Shimaoka M. Cellular and Exosomal Regulations of Sepsis-Induced Metabolic Alterations. Int J Mol Sci 2021;22:8295. [PMID: 34361061 DOI: 10.3390/ijms22158295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]